DexCom Inc - Company Profile
Powered by
All the data and insights you need on DexCom Inc in one report.
- Save hours of research time and resources with
our up-to-date DexCom Inc Strategy Report
- Understand DexCom Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Dexcom Inc (Dexcom) designs, develops and commercializes continuous glucose monitoring (CGM) systems use by people with diabetes and healthcare providers in the hospital. The company’s major products include integrated Dexcom G6 CGM system, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products directly in the US, Austria, Canada, Germany, Switzerland and the UK, and also through a network of distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.
DexCom Inc premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
DexCom G6 CGM System | - | - |
Dexcom G7 | Support | DexCom G6 |
DexCom Share System | Training | DexCom Share |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company and MD Revolution entered into a partnership to combine their continuous glucose monitoring systems with MD Revolution’s remote care management platform. |
2024 | Regulatory Approval | In March, the company secured approval from the FDA for the Stelo by Dexcom. |
2024 | New Products/Services | In February, the company launched the new continuous glucose monitoring (CGM) system, Dexcom ONE+. |
Competitor Comparison
Key Parameters | DexCom Inc | Becton Dickinson and Co | Roche Diagnostics International Ltd | Abbott Diabetes Care Inc | Ascensia Diabetes Care US Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | Switzerland | United States of America | United States of America |
City | San Diego | Franklin Lakes | Rotkreuz | Indianapolis | Parsippany |
State/Province | California | New Jersey | Zug | Indiana | New Jersey |
No. of Employees | 9,600 | 73,000 | 2,600 | - | - |
Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Kevin R. Sayer | Chief Executive Officer; President; Chairman | Executive Board | 2018 | 65 |
Jereme M. Sylvain | Chief Financial Officer; Executive Vice President | Senior Management | 2021 | 43 |
Jacob S. Leach | Chief Operating Officer; Executive Vice President | Senior Management | 2022 | 45 |
Shelly R. Selvaraj | Senior Vice President; Chief Information Officer | Senior Management | 2021 | 64 |
Girish Naganathan | Executive Vice President; Chief Technology Officer | Senior Management | 2022 | 46 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer